Related Experiment Video
Updated: Jan 18, 2026
12:58
A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
9.3K
Metronidazole-An Old Drug for Structure Optimization and Repurposing.
Vasanti Suvarna1, Manikanta Murahari2, Shrutee Pawar1
1Department of Quality Assurance, SVKM's Dr. Bhanuben Nanavati College of Pharmacy, Mumbai, Maharashtra, India.
Chemistry & Biodiversity
|June 7, 2025
Summary
Metronidazole remains crucial for anaerobic and parasitic infections. New analogs are being developed to combat antimicrobial resistance and expand therapeutic applications.
Area of Science:
- Microbiology
- Medicinal Chemistry
- Pharmacology
Background:
- Metronidazole is a vital nitroimidazole prodrug effective against anaerobic bacteria, microaerophilic organisms, and protozoa.
- Its mechanism involves enzymatic reduction under low-oxygen conditions, generating cytotoxic intermediates.
- Rising antimicrobial resistance necessitates the development of novel metronidazole analogs.
Purpose of the Study:
- To review the clinical relevance of metronidazole and its metabolite structure-cytotoxicity relationship.
- To highlight advancements in metronidazole derivative synthesis.
- To evaluate the therapeutic benefits of new analogs compared to the original compound.
Main Methods:
- Literature review of metronidazole's clinical use and resistance patterns.
- Analysis of studies on metronidazole metabolite structure and cytotoxicity in human and rodent models.
- Synthesis and comparative evaluation of novel metronidazole derivatives (e.g., ruthenium-based, Schiff bases).
Main Results:
- Metronidazole's efficacy is linked to its reduction products, with varying cytotoxic effects observed in different models.
- New analogs demonstrate broader antimicrobial spectra and improved activity against resistant strains.
- Ruthenium-based compounds and Schiff base derivatives show promise for enhanced efficacy and reduced toxicity.
Conclusions:
- Metronidazole continues to be a cornerstone antimicrobial, but resistance is a growing concern.
- Novel metronidazole analogs offer potential solutions to resistance and expanded therapeutic uses.
- Further research into structure-activity relationships is crucial for optimizing next-generation antimicrobial agents.
Related Concept Videos
01:27Phase I Reactions: Reductive Reactions
578
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
578
01:28Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.6K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the para...
3.6K
01:27Combined Effects of Drugs: Synergism
6.8K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.8K
01:16Drug Biotransformation: Overview
3.7K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.7K
01:13meta-Directing Deactivators: –NO2, –CN, –CHO, –CO2R, –COR, –CO2H
6.6K
All meta-directing substituents are deactivating groups. These substituents withdraw electrons from the aromatic ring, making the ring less reactive toward electrophilic substitution. For example, the nitration of nitrobenzene is 100,000 times slower than that of benzene because of the deactivating effect of the nitro group. The first step in an electrophilic aromatic substitution is the addition of an electrophile to form a resonance-stabilized carbocation. The energy diagrams for...
6.6K